DLB
NYSE · Technology
Dolby Laboratories Inc-Cl A
$65.13
+0.31 (+0.48%)
Financial Highlights (FY 2026)
Revenue
1.29B
Net Income
243.88M
Gross Margin
88.1%
Profit Margin
18.9%
Rev Growth
+2.5%
D/E Ratio
—
Revenue & Net Income
Margin Trends
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Gross Margin | 88.1% | 88.1% | 67.0% | 67.0% |
| Operating Margin | 19.6% | 17.7% | 20.7% | 16.6% |
| Profit Margin | 18.9% | 18.0% | 16.8% | 18.2% |
Income Statement
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Revenue | 1.29B | 1.26B | 1.67B | 1.72B |
| Gross Profit | 1.14B | 1.11B | 1.12B | 1.15B |
| Operating Income | 253.40M | 222.56M | 346.54M | 285.50M |
| Net Income | 243.88M | 214.20M | 280.66M | 311.42M |
| Gross Margin | 88.1% | 88.1% | 67.0% | 67.0% |
| Operating Margin | 19.6% | 17.7% | 20.7% | 16.6% |
| Profit Margin | 18.9% | 18.0% | 16.8% | 18.2% |
| Rev Growth | +2.5% | +2.5% | +5.4% | -9.3% |
Balance Sheet
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Total Debt | 0 | 0 | 2.47B | 2.76B |
| Total Equity | — | — | 3.67B | 3.88B |
| D/E Ratio | — | — | 0.67 | 0.71 |
Cash Flow
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| EBITDA | 337.38M | 312.79M | 450.61M | 440.76M |
| Free Cash Flow | — | — | 238.46M | 212.55M |